ArticleStem cell research & therapy2018

Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.

Cuicui Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.